Investments

Royal Biologics, developer of products for regenerative medicine, received funding to support employee onboarding, operational growth, product development and acquisitions. ...

InGeneron has extended its Series D financing to USD $43MM to bring regenerative cell therapy for rotator cuff tears into clinical...

Catalyst OrthoScience raised US $12.7MM to support growth of its Catalyst CSR Total Shoulder....

ApiFix completed its Series B financing round and is preparing for U.S. commercial launch of its MID-C System to treat pediatric scoliosis....

HAPPE Spine received a second round of financing. The company is developing material technology that allows for the construction of partial...

Intrinsic Therapeutics completed a US $52MM equity financing. Proceeds will support U.S. commercialization of the Barricaid® anular closure device....

Alphatec will receive US $30MM in secured debt financing from Squadron Capital. Proceeds will support company growth....

Medacta launches IPO with base size of CHF 547MM (USD $547.8MM), with 5.7 million shares offered at a price of...

Hyalex Orthopaedics, developer of HYALEX synthetic polymer that is designed to mimic hyaline cartilage, grew its original Series A funding to US...

Graftys completed a ‚¬4.1MM (~US $4.6MM) funding round. Proceeds will support commercialization of QuickSet cement and HBS injectable calcium phosphate bone graft substitute....